Besides, other peptide vaccines, such as the aspartate-hydroxylase vaccine, the HA (the fusion of high-mobility group nucleosome binding protein 1 and AFP) vaccine, and the VEGF vaccine, also have promising applications in the treatment of HCC [221–223]. This evidence concerns the gene AFP and hepatocellular carcinoma.